The role of UPS in most carcinogenesis-related processes and the clinical success of its inhibition by the boronic acid derivative bortezomib in multiple myeloma have confirmed UPS as a valid anti-neoplastic target [121]. The gene discussed is HMBS; the disease is AL amyloidosis.